Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Open accessThe DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) is increasingly recognized in infections among persons in the community without established risk factors for MRSA. METHODS: We enrolled adult patients with acute, purulent skin and soft-tissue infections presenting to 11 university-affiliated emergency departments during the month of August 2004. Cultures were obtained, and clinical information was collected. Available S. aureus isolates were characterized by antimicrobial-susceptibility testing, pulsed-field gel electrophoresis, and detection of toxin genes. On MRSA isolates, we performed typing of the staphylococcal cassette chromosome mec (SCCmec), the genetic element that carries the mecA gene encoding methicillin resistance. RESULTS: S. aureus was isolated from 320 of 422 patients with skin and soft-tissue infections (76 percent). The prevalence of MRSA was 59 percent overall and ranged from 15 to 74 percent. Pulsed-field type USA300 isolates accounted for 97 percent of MRSA isolates; 74 percent of these were a single strain (USA300-0114). SCCmec type IV and the Panton-Valentine leukocidin toxin gene were detected in 98 percent of MRSA isolates. Other toxin genes were detected rarely. Among the MRSA isolates, 95 percent were susceptible to clindamycin, 6 percent to erythromycin, 60 percent to fluoroquinolones, 100 percent to rifampin and trimethoprim-sulfamethoxazole, and 92 percent to tetracycline. Antibiotic therapy was not concordant with the results of susceptibility testing in 100 of 175 patients with MRSA infection who received antibiotics (57 percent). Among methicillin-susceptible S. aureus isolates, 31 percent were USA300 and 42 percent contained pvl genes. CONCLUSIONS: MRSA is the most common identifiable cause of skin and soft-tissue infections among patients presenting to emergency departments in 11 U.S. cities. When antimicrobial therapy is indicated for the treatment of skin and soft-tissue infections, clinicians should consider obtaining cultures and modifying empirical therapy to provide MRSA coverage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A recently published study of 422 patients with SSTI from 11 EDs in the United States reported that the prevalence of MRSA was 59%. 15”
From Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department (2009) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“In other research, IDU was strongly linked to MRSA SSTI in homeless individuals, 7 but this association was not found in 2 ED-based studies. 8,15”
From Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department (2009) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489
Naimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688
Methicillin-Resistant Staphylococcus aureus Disease in Three Communities
Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., & Farley, M. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043252 · Cited by 1,493
Herold, B. C. (1998) · JAMA · doi:10.1001/jama.279.8.593 · Cited by 1,412
McDougal, L. K., Steward, C. D., Killgore, G. E., Chaitram, J. M., McAllister, S. K., & Tenover, F. C. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5113-5120.2003 · Cited by 1,399
Self-citationA Clone of Methicillin-Resistant Staphylococcus aureus among Professional Football Players
Kazakova, S. V., Hageman, J. C., Matava, M., Srinivasan, A., Phelan, L., Garfinkel, B., Boo, T., McAllister, S., Anderson, J., Jensen, B., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042859 · Cited by 741
Self-citationFrancis, J. S., Doherty, M. C., Lopatin, U., Johnston, C. P., Sinha, G., Ross, T., Cai, M., Hansel, N. N., Perl, T., Ticehurst, J. R., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/427148 · Cited by 719
Barrett, F. F., McGehee, R. F., & Finland, M. (1968) · New England Journal of Medicine · doi:10.1056/nejm196808292790901 · Cited by 512
Frazee, B. W., Lynn, J., Charlebois, E. D., Lambert, L., Lowery, D., & Perdreau-Remington, F. (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.10.011 · Cited by 494
Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue Infections
Weigelt, J., Itani, K., Stevens, D., Lau, W., Dryden, M., & Knirsch, C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2260-2266.2005 · Cited by 457
Research works printed but not linked: 3
- 2003, MMWR Morb Mortal Wkly Rep, 52, 88
- Bannerman TL. Staphylococci and other catalase positive cocci that grow aerobically. In: Murray PR, Baron EJ, Jogensen JH, eds. Manual of clinical microbiology. 8th ed. Washington, D.C.: ASM Press, 2003:384-404.
- 10.1097/00006454-200307000-00006 · doi:10.1097/00006454-200307000-00006
Cited by
Items 301–400 of 1,001
Summary of Ceftaroline Fosamil Clinical Trial Studies and Clinical Safety
File, T. M., Wilcox, M. H., & Stein, G. E. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis559 · Cited by 102
Epidemiology of meticillin-resistant Staphylococcus aureus (MRSA) in Latin America
Guzmán-Blanco, M., Mejía, C., Istúriz, R., Álvarez, C., Luis Bavestrello, F., Gotuzzo, E., Labarca, J. A., Luna, C. M., Rodríguez-Noriega, E., Salles, M. J. C., et al. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.06.005 · Cited by 133
Saeed, K. B. A., Gould, I. M., Esposito, S., Ahmad-Saeed, N., Ahmed, S. S., Alp, E., Bal, A. M., Bassetti, M., Bonnet, É., Chan, M., et al. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.11.002 · Cited by 116
Bae, I.-G., Tonthat, G. T., Stryjewski, M. E., Rude, T. H., Reilly, L. F., Barriere, S. L., Genter, F. C., Corey, G. R., & Fowler, V. G. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01643-09 · Cited by 99
Crum‐Cianflone, N. F., Grandits, G., Echols, S., Ganesan, A., Landrum, M. L., Weintrob, A., Barthel, R., & Agan, B. K. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181c8ef22 · Cited by 101
Necrotizing soft-tissue infections
Ustin, J. S., & Malangoni, M. A. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821cb246 · Cited by 102
Sader, H. S., & Jones, R. N. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.06.016 · Cited by 100
O’Riordan, W. D., Mehra, P., Manos, P., Kingsley, J., Lawrence, L. E., & Cammarata, S. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.10.009 · Cited by 102
Diagnostic accuracy in patients admitted to hospitals with cellulitis
David, C. V., Chira, S., Eells, S. J., Ladrigan, M. K., Papier, A., Miller, L. G., & Craft, N. A. (2011) · Dermatology Online Journal · doi:10.5070/d39gn050rr · Cited by 103
Clinical Importance and Epidemiology of Quinolone Resistance
Kim, E. S., & Hooper, D. C. (2014) · Infection and Chemotherapy · doi:10.3947/ic.2014.46.4.226 · Cited by 118
Virulence Gene Expression in Human Community‐Acquired Staphylococcus aureus Infection
Loughman, J. A., Fritz, S. A., Storch, G. A., & Hunstad, D. A. (2009) · The Journal of Infectious Diseases · doi:10.1086/595982 · Cited by 100
Evolving problems with resistant pathogens
Chastre, J. E. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01958.x · Cited by 113
Role of gamma-delta T cells in host response against Staphylococcus aureus-induced pneumonia
Cheng, P., Liu, T., Zhou, W., Zhuang, Y., Peng, L., Zhang, J., Yin, Z., Mao, X., Guo, G., Shi, Y., et al. (2012) · BMC Immunology · doi:10.1186/1471-2172-13-38 · Cited by 103
Mohammad, H., Reddy, P. V., Monteleone, D., Mayhoub, A. S., Cushman, M., & Seleem, M. N. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.03.015 · Cited by 105
Zhu, Y. M., Xu, J., Wang, Y., Chen, C., Gu, H., Chai, Y., & Wang, Y. (2020) · Nano Research · doi:10.1007/s12274-020-2621-3 · Cited by 97
Guo, Y., Huang, E., Yuan, C., Zhang, L., & Yousef, A. E. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.07782-11 · Cited by 114
Beibei, L., Yun, C., Mengli, C., Nan, B., Xuhong, Y., & Wang, R. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.09.013 · Cited by 97
Kollef, M. H., Zilberberg, M. D., Shorr, A. F., Vo, L., Schein, J. R., Micek, S. T., & Kim, M. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.12.009 · Cited by 97
Fritz, S. A., Epplin, E. K., Garbutt, J., & Storch, G. A. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.09.001 · Cited by 95
Sande-Lopez, L., Sanchez, M., Montes, J., Wolf, A. J., Morgan, M. A., Omri, A., & Liu, G. Y. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks212 · Cited by 97
Mera, R. M., Suaya, J. A., Amrine‐Madsen, H., Hogea, C. S., Miller, L. A., Lu, E., Sahm, D. F., O’Hara, P. J., & Acosta, C. J. (2011) · Microbial Drug Resistance · doi:10.1089/mdr.2010.0193 · Cited by 114
High Prevalence of EMRSA-15 in Portuguese Public Buses: A Worrisome Finding
Simões, R. R., Aires-de-Sousa, M., Conceição, T., Antunes, F., da Costa, P. M., & de LENCASTRE, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017630 · Cited by 105
Ferreira, J. P., Anderson, K. L., Correa, M. T., Lyman, R. L., Ruffin, F., Reller, L. B., & Fowler, V. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026978 · Cited by 98
Dalbavancin: a Novel Once-Weekly Lipoglycopeptide Antibiotic
Saravolatz, L. D., Billeter, M., Zervos, M., Chen, A. Y., Dalovisio, J. R., & Kurukularatne, C. (2008) · Clinical Infectious Diseases · doi:10.1086/526772 · Cited by 96
David, M. Z., Daum, R. S., Bayer, A. S., Chambers, H. F. “., Fowler, V. G., Miller, L. G., Ostrowsky, B. E., Baesa, A., Boyle‐Vavra, S., Eells, S. J., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu410 · Cited by 99
Pragmatic management of Panton–Valentine leukocidin-associated staphylococcal diseases
Gillet, Y., Dumitrescu, O., Tristan, A., Dauwalder, O., Javouhey, É., Floret, D., Vandenesch, F., Étienne, J., & Lina, G. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.05.003 · Cited by 102
Farrell, D. J., Robbins, M. J., Rhys‐Williams, W., & Love, W. G. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01285-10 · Cited by 98
David, M. Z., Boyle-Vavra, S., Zychowski, D. L., & Daum, R. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018217 · Cited by 84
Structural Studies of Pterin-Based Inhibitors of Dihydropteroate Synthase
Hevener, K. E., Yun, M., Qi, J., Kerr, I. D., Babaoglu, K., Hurdle, J. G., Balakrishna, K., White, S. W., & Lee, R. E. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900861d · Cited by 103
Noto, M. J., Kreiswirth, B. N., Monk, A. B., & Archer, G. L. (2007) · Journal of Bacteriology · doi:10.1128/jb.01128-07 · Cited by 114
Virulence attributes of successful methicillin-resistant Staphylococcus aureus lineages
Jiang, J.-H., Cameron, D. R., Nethercott, C., Aires-de-Sousa, M., & Peleg, A. Y. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00148-22 · Cited by 92
Agents for the Decolonization of Methicillin‐Resistant Staphylococcus aureus
McConeghy, K. W., Mikolich, D. J., & LaPlante, K. L. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.3.263 · Cited by 102
Chua, K. Y. L., Seemann, T., Harrison, P. F., Monagle, S., Korman, T. M., Johnson, P. D. R., Coombs, G. W., Howden, B. O., Davies, J. K., Howden, B. P., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025887 · Cited by 92
Shore, A. C., Brennan, O. M., Ehricht, R., Monecke, S., Schwarz, S., Slickers, P., & Coleman, D. C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01113-10 · Cited by 90
Sen, S., Sirobhushanam, S., Johnson, S. R., Song, Y., Tefft, R., Gatto, C., & Wilkinson, B. J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0165300 · Cited by 93
Staphylococcus aureus Pneumonia in the Community
He, H., & Wunderink, R. G. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0040-1709992 · Cited by 81
Moran, G. J., Krishnadasan, A., Mower, W. R., Abrahamian, F. M., LoVecchio, F., Steele, M. T., Rothman, R. E., Karras, D. J., Hoagland, R. J., Pettibone, S., et al. (2017) · JAMA · doi:10.1001/jama.2017.5653 · Cited by 100
Self-citationLoewen, K., Schreiber, Y., Kirlew, M., Bocking, N., & Kelly, L. (2017) · Europe PMC (PubMed Central) · Cited by 135
Thompson, J. M., Gündoğdu, A., Stratton, H. M., & Katouli, M. (2012) · Journal of Applied Microbiology · doi:10.1111/jam.12037 · Cited by 91
Lautenbach, E., Nachamkin, I., Hu, B., Fishman, N. O., Tolomeo, P., Prasad, P. A., Bilker, W. B., & Zaoutis, T. E. (2009) · Infection Control and Hospital Epidemiology · doi:10.1086/596045 · Cited by 101
Plano, L. R. W., Garza, A. C., Shibata, T., Elmir, S. M., Kish, J. K., Sinigalliano, C. D., Gidley, M. L., Miller, G. A., Withum, K. F., Fleming, L. E., et al. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-5 · Cited by 102
Duane, T. M., Huston, J. M., Collom, M., Beyer, A., Parli, S. E., Buckman, S. A., Shapiro, M. A., McDonald, A. A., Diaz, J. J., Tessier, J. M., et al. (2021) · Surgical Infections · doi:10.1089/sur.2020.436 · Cited by 106
Katz, D. E., Lindfield, K. C., Steenbergen, J. N., Benziger, D. P., Blackerby, K. J., Knapp, A. G., & Martone, W. J. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01854.x · Cited by 93
Mohammad, H. T., Mayhoub, A. S., Cushman, M., & Seleem, M. N. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2014.142 · Cited by 90
Louie, A., Liu, W., Kulawy, R., & Drusano, G. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01565-10 · Cited by 90
Prokocimer, P., Bien, P. A., DeAnda, C., Pillar, C. M., & Bartizal, K. F. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00458-12 · Cited by 89
Eckmann, C., & Dryden, M. (2010) · European journal of medical research · doi:10.1186/2047-783x-15-12-554 · Cited by 89
Otter, J. A., & French, G. L. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02017.x · Cited by 101
Staphylococcus aureus in the Community: Colonization Versus Infection
Miller, M., Cook, H. A., Furuya, E. Y., Bhat, M., Lee, M., Vavagiakis, P., Visintainer, P., Vasquez, G., Larson, E., & Lowy, F. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006708 · Cited by 103
Diep, B. A., Afasizheva, A., Le, H. N., Kajikawa, O., Matute‐Bello, G., Tkaczyk, C., Sellman, B. R., Badiou, C., Lina, G., & Chambers, H. F. “. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit129 · Cited by 90
Malignant Otitis Externa: Evolving Pathogens and Implications for Diagnosis and Treatment
Hobson, C. E., Moy, J. D., Byers, K. E., Raz, Y., Hirsch, B. E., & McCall, A. A. (2014) · Otolaryngology · doi:10.1177/0194599814528301 · Cited by 89
Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo
Durupt, F., Mayor, L., Bes, M., Reverdy, M. E., Vandenesch, F., Thomas, L., & Étienne, J. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08197.x · Cited by 98
Kwak, Y. G., Choi, S., Kim, T., Park, S. Y., Seo, S. H., Kim, M. B., & Choi, S. (2017) · Infection and Chemotherapy · doi:10.3947/ic.2017.49.4.301 · Cited by 90
Innate Immunity to Staphylococcus aureus: Evolving Paradigms in Soft Tissue and Invasive Infections
Brandt, S. L., Putnam, N. E., Cassat, J. E., & Serezani, C. H. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701574 · Cited by 93
Palavecino, E. L. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-468-1_1 · Cited by 107
Milstone, A. M., Goldner, B. W., Ross, T., Shepard, J. W., Carroll, K. C., & Perl, T. M. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir547 · Cited by 89
Wang, J., Liao, C., Fang, C., Chie, W., Lai, M., Lauderdale, T.-L. Y., Lee, W., Huang, J.-H., & Chang, S. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00853-09 · Cited by 101
Role of Staphylococcus aureus Catalase in Niche Competition against Streptococcus pneumoniae
Park, B., Nizet, V., & Liu, G. Y. (2008) · Journal of Bacteriology · doi:10.1128/jb.00006-08 · Cited by 87
Ho, P., Chuang, S. K., Choi, Y.-F., Lee, R. A., Lit, A. C., Ng, T. K., Que, T., Shek, K.-C., Tong, H.-K., Tse, C. W. S., et al. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.12.015 · Cited by 100
Burden of Methicillin‐Resistant Staphylococcus aureus: Focus on Clinical and Economic Outcomes
Lodise, T. P., & McKinnon, P. S. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.7.1001 · Cited by 106
Chhibber, S., Shukla, A., & Kaur, S. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02146-16 · Cited by 78
Community-acquired methicillin-resistant Staphylococcus aureus: what do we need to know?
Witte, W. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03097.x · Cited by 103
Fraimow, H. S., & Tsigrelis, C. (2010) · Critical Care Clinics · doi:10.1016/j.ccc.2010.11.002 · Cited by 106
Davis, S. L., McKinnon, P. S., Hall, L. M., Delgado, G., Rose, W. E., Wilson, R. F., & Rybak, M. J. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.12.1611 · Cited by 87
Watkins, R., Lemonovich, & File, T. M. (2012) · Core evidence · doi:10.2147/ce.s33430 · Cited by 98
Zhao, H., Li, W., Gao, Y., Li, J., & Wang, H. (2014) · Toxicology · doi:10.1016/j.tox.2014.09.006 · Cited by 88
Villaruz, A. E., Wardenburg, J. B., Khan, B. A., Whitney, A. R., Sturdevant, D. E., Gardner, D. J., DeLeo, F. R., & Otto, M. (2009) · The Journal of Infectious Diseases · doi:10.1086/604728 · Cited by 87
Elie-Turenne, M.-C., Fernandes, H., Mediavilla, J. R., Rosenthal, M. E., Mathema, B., Singh, A., Cohen, T. R., Pawar, K. A., Shahidi, H., Kreiswirth, B. N., et al. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/652525 · Cited by 100
Moran, G. J., Abrahamian, F. M., LoVecchio, F., & Talan, D. A. (2013) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2012.11.050 · Cited by 89
Self-citationNovel targeted immunotherapy approaches for staphylococcal infection
Otto, M. J. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2010.495115 · Cited by 93
Liposomal antibiotics for the treatment of infectious diseases
Alhariri, M., Azghani, A. O., & Omri, A. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.822860 · Cited by 86
Olaniyi, R., Pozzi, C., Grimaldi, L., & Bagnoli, F. (2016) · Current topics in microbiology and immunology · doi:10.1007/82_2016_32 · Cited by 94
Uhlemann, A., McAdam, P. R., Sullivan, S. B., Knox, J., Khiabanian, H., Rabadán, R., Davies, P. R., Fitzgerald, J. R., & Lowy, F. D. (2017) · mBio · doi:10.1128/mbio.01375-16 · Cited by 91
Paukner, S., Sader, H. S., Ivezic‐Schoenfeld, Z., & Jones, R. N. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00358-13 · Cited by 84
Castillo-Neyra, R., Frisancho, J. A., Rinsky, J. L., Resnick, C., Carroll, K. C., Rule, A. M., Ross, T. L., You, Y., Price, L. B., & Silbergeld, E. K. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1306741 · Cited by 84
Guo, Y., Ramos, R. I., Cho, J. S., Donegan, N. P., Cheung, A. L., & Miller, L. S. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01003-12 · Cited by 98
Rehm, S. J., & Tice, A. D. (2010) · Clinical Infectious Diseases · doi:10.1086/653518 · Cited by 85
Duplessis, C. A., & Crum‐Cianflone, N. F. (2011) · Clinical Medicine Reviews in Therapeutics · doi:10.4137/cmrt.s1637 · Cited by 83
How Common is MRSA in Adult Septic Arthritis?
Frazee, B. W., Fee, C. R., & Lambert, L. (2009) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2009.06.511 · Cited by 83
Acute bacterial skin infections and cellulitis
Gabillot-Carré, M., & Roujeau, J. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32805dfb2d · Cited by 87
Parapneumonic Empyema Deaths during Past Century, Utah
Bender, J. M., Ampofo, K., Sheng, X., Pavia, A. T., Cannon‐Albright, L., & Byington, C. L. (2009) · Emerging infectious diseases · doi:10.3201/eid1501.080618 · Cited by 88
Antibiotic Overuse: The Influence of Social Norms
(2008) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2008.02.035 · Cited by 80
Mansour, S., Pletzer, D., de la Fuente‐Núñez, C., Kim, P., Cheung, G. Y. C., Joo, H., Otto, M. J., & Hancock, R. E. W. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.09.015 · Cited by 89
Community-Associated Methicillin-Resistant Staphylococcus aureus
Wallin, T. R., Hern, H. G., & Frazee, B. W. (2008) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2008.01.010 · Cited by 98
Ellington, M. J., Yearwood, L., Ganner, M., East, C., & Kearns, A. M. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm422 · Cited by 80
The adherens junctions control susceptibility to Staphylococcus aureus α-toxin
Popov, L. M., Marceau, C. D., Starkl, P. M., Lumb, J. H., Shah, J., Guerrera, D., Cooper, R. L., Merakou, C., Bouley, D. M., Meng, W., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510265112 · Cited by 87
An update on community-associated MRSA virulence
Kobayashi, S. D., & DeLeo, F. R. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.07.009 · Cited by 92
Recurrent furunculosis: a review of the literature
Demos, M., McLeod, M. P., & Nouri, K. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11151.x · Cited by 81
Breast Implant Infections: Is Cefazolin Enough?
Feldman, E. M., Kontoyiannis, D. P., Sharabi, S. E., Lee, E. W., Kaufman, Y., & Heller, L. (2010) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3181e5f7ff · Cited by 81
Elliott, D., Zaoutis, T., Troxel, A., Loh, A., & Keren, R. (2009) · Pediatrics · doi:10.1542/peds.2008-2428 · Cited by 91
Patients’ Bath Basins as Potential Sources of Infection: A Multicenter Sampling Study
Johnson, D., Lineweaver, L., & Maze, L. M. (2009) · American Journal of Critical Care · doi:10.4037/ajcc2009968 · Cited by 81
Talan, D. A., Salhi, B. A., Moran, G. J., Mower, W. R., Hsieh, Y., Krishnadasan, A., & Rothman, R. E. (2015) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2014.11.24133 · Cited by 85
Self-citationRecent advances in Staphylococcus aureus infection: focus on vaccine development
Ansari, S., Jha, R. K., Mishra, S. K., Tiwari, B. R., & Asaad, A. M. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s175014 · Cited by 89
Kennedy, A. D., Porcella, S. F., Martens, C., Whitney, A. R., Braughton, K. R., Chen, L., Craig, C. T., Tenover, F. C., Kreiswirth, B. N., Musser, J. M., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01050-10 · Cited by 92
Control of Adaptive Immune Responses by Staphylococcus aureus through IL-10, PD-L1 and TLR2
Wang, J., Roderiquez, G., & Norcross, M. A. (2012) · Scientific Reports · doi:10.1038/srep00606 · Cited by 89
Hair, P. I., & Keam, S. J. (2007) · Drugs · doi:10.2165/00003495-200767100-00008 · Cited by 90
Huang, A. D., Luo, C., Peña, Á., Weigand, M. R., Tarr, C. L., & Konstantinidis, K. T. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.02577-16 · Cited by 93
The Heme Sensor System of Staphylococcus aureus
Stauff, D. L., & Skaar, E. P. (2009) · Contributions to Microbiology · doi:10.1159/000219376 · Cited by 83
Glikman, D., Siegel, J. D., David, M. Z., Okoro, N., Boyle‐Vavra, S., Dowell, M. L., & Daum, R. S. (2008) · CHEST Journal · doi:10.1378/chest.07-2437 · Cited by 82
Effect of medical honey on wounds colonised or infected with MRSA
Blaser, G., Santos, K., Bode, U., Vetter, H., & Simon, A. (2007) · Journal of Wound Care · doi:10.12968/jowc.2007.16.8.27851 · Cited by 78
Metadata
- Authors
- Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A.
- Affiliations
- Olive View-UCLA Medical Center (US)
- Centers for Disease Control and Prevention (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-08-17
- Volume
- 355
- Issue
- 7
- Pages
- 666-674
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2131316809
- Cited by
- 2,285
- References
- 35
- Citations by year
- 2026: 28 · 2025: 39 · 2024: 58 · 2023: 39 · 2022: 42 · 2021: 55 · 2020: 57 · 2019: 76 · 2018: 83 · 2017: 72 · 2016: 93 · 2015: 125 · 2014: 117 · 2013: 145 · 2012: 170
- FWCI
- 138.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention (U01CI000353)
- U.S. Public Health Service (U50/CCU912342)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Infectious Diseases › Dermatological diseases and infestations
- Keywords
- methicillin-resistant Staphylococcus aureus, skin and soft tissue infections, emergency department patients, community-acquired MRSA, USA300, Panton-Valentine leukocidin, antibiotic susceptibility, empirical antibiotic therapy, antimicrobial resistance, methicillin-susceptible Staphylococcus aureus
- MeSH terms
- Acute Disease, Adult, Aged, Anti-Bacterial Agents, Bacterial Proteins, Bacterial Toxins, Emergency Service, Hospital, Exotoxins, Female, Humans, Leukocidins, Male, Microbial Sensitivity Tests, Middle Aged, Staphylococcal Infections, Staphylococcal Skin Infections, Staphylococcus aureus, United States, Methicillin Resistance, Electrophoresis, Gel, Pulsed-Field, Soft Tissue Infections, Penicillin-Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.